ST Phi Therapeutics, Inc.
Biotechnology company · Seattle, Washington, United States
ST Phi Therapeutics, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $500,000 sold in a notice filed in 2018.
ST Phi Therapeutics at a glance
What does ST Phi Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $500,000 sold (2018).
Frequently asked questions about ST Phi Therapeutics
Where is ST Phi Therapeutics headquartered?
ST Phi Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does ST Phi Therapeutics do?
ST Phi Therapeutics, Inc. is a biotechnology company.
When was ST Phi Therapeutics founded?
The earliest incorporation on record for ST Phi Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Kineta, Inc.Seattle, Washington, United States
- Avm Biotechnology, LLCSeattle, Washington, United States
- Lumen Bioscience, Inc.Seattle, Washington, United States
- Presage Biosciences, Inc.Seattle, Washington, United States
- Sana Biotechnology, Inc.Seattle, Washington, United States
- Phase Genomics, Inc.Seattle, Washington, United States
- Soovu Labs, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences